Aerosolized Lipid Amphotericin B for Complementary Therapy and/or Secondary Prophylaxis in Patients with Invasive Pulmonary Aspergillosis: A Single-Center Experience-Reference-Cited by-同舟云学术

Aerosolized Lipid Amphotericin B for Complementary Therapy and/or Secondary Prophylaxis in Patients with Invasive Pulmonary Aspergillosis: A Single-Center Experience

Published:2019-03-22 Issue:2 Volume:184 Page:239-250
ISSN:0301-486X
Container-title:Mycopathologia
language:en
Short-container-title:Mycopathologia

Author:

Venanzi E.,Martín-Dávila P.,López J.,Maiz L.,de la Pedrosa E. Gómez-García,Gioia F.,Escudero R.,Filigheddu E.,Moreno S.,Fortún J.^ORCID

Funder

REIPI

Publisher

Springer Science and Business Media LLC

Subject

Veterinary (miscalleneous),Agronomy and Crop Science,Applied Microbiology and Biotechnology,Microbiology

Link

http://link.springer.com/content/pdf/10.1007/s11046-019-00331-0.pdf

Reference29 articles.

1. Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE). Lancet. 2016;387(10020):760–9.

2. Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1–38.

3. Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;63(4):e1–60.

4. Monforte V, Ussetti P, López R, Gavalda J, Bravo C, de Pablo A, et al. Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety. J Heart Lung Transpl. 2009;28(2):170–5.

5. Adler-Moore JP, Proffitt RT, Olson JA, Jensen GM. Tissue pharmacokinetic and pharmacodynamics of Ambisome (L-AmBis) in uninfected and infected animals and their effects on dosing regimens. J Liposome Res. 2017;27(3):195–209.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating Uncertainty: Managing Influenza-Associated Invasive Pulmonary Aspergillosis in an Intensive Care Unit;Journal of Fungi;2024-09-07

2. A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis;Journal of Fungi;2024-03-01

3. Clinical Uses of Inhaled Antifungals for Invasive Pulmonary Fungal Disease: Promises and Challenges;Journal of Fungi;2023-04-12

4. Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections;Pharmaceutics;2022-03-14

5. Antifungals in Clinical Use and the Pipeline;Infectious Disease Clinics of North America;2021-06